China Shineway Pharmaceutical Group Limited - Asset Resilience Ratio

Latest as of December 2025: 3.49%

China Shineway Pharmaceutical Group Limited (C1S) has an Asset Resilience Ratio of 3.49% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€376.64 Million

≈ $440.33 Million USD Cash + Short-term Investments

Total Assets

€10.78 Billion

≈ $12.60 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how China Shineway Pharmaceutical Group Limited's Asset Resilience Ratio has changed over time. Check China Shineway Pharmaceutical Group Limi strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down China Shineway Pharmaceutical Group Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see China Shineway Pharmaceutical Group Limi market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€376.64 Million	3.49%
Total Liquid Assets	€376.64 Million	3.49%

Asset Resilience Insights

Limited Liquidity: China Shineway Pharmaceutical Group Limited maintains only 3.49% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

China Shineway Pharmaceutical Group Limited Industry Peers by Asset Resilience Ratio

Compare China Shineway Pharmaceutical Group Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for China Shineway Pharmaceutical Group Limited (2017–2025)

The table below shows the annual Asset Resilience Ratio data for China Shineway Pharmaceutical Group Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	3.49%	€376.64 Million ≈ $440.33 Million	€10.78 Billion ≈ $12.60 Billion	+0.01pp
2024-12-31	3.49%	€350.02 Million ≈ $409.21 Million	€10.04 Billion ≈ $11.74 Billion	+3.28pp
2023-12-31	0.21%	€20.00 Million ≈ $23.38 Million	€9.57 Billion ≈ $11.19 Billion	-0.04pp
2022-12-31	0.25%	€20.23 Million ≈ $23.65 Million	€8.23 Billion ≈ $9.62 Billion	+0.14pp
2018-12-31	0.11%	€7.19 Million ≈ $8.41 Million	€6.73 Billion ≈ $7.87 Billion	-0.15pp
2017-12-31	0.25%	€16.91 Million ≈ $19.77 Million	€6.67 Billion ≈ $7.79 Billion	--

pp = percentage points

About China Shineway Pharmaceutical Group Limited

F:C1S Germany Drug Manufacturers - Specialty & Generic

Market Cap

$772.75 Million

€660.98 Million EUR

Market Cap Rank

#10147 Global

#1226 in Germany

Share Price

€0.88

Change (1 day)

-1.13%

52-Week Range

€0.80 - €1.09

All Time High

€1.25